glp-1 news 2025 october 21 trends 2025: real-world data, patient outcomes & future therapies GLP-1 Trends

For me, NAD is no longer just a side playerits going front and center in my supplement stack

This next step in our partnership with the MHRA will generate data and evidence for safer and more effective treatment through more personalised approaches to prescription, supporting a shift towards an increasingly prevention-focused healthcare system. "Patient safety is of the utmost importance to Novo Nordisk

CrossRef Dual roles and mechanisms of adipokines in nerve injury repair and pain regulation: a research review Yubing Lu, Yishan Xin, Hongyan Li, Xinyu Fang, Yunzhi Lin, Chaofan Zhang International Immunopharmacology.2026